Rare diseases
Investigational molecules
Locations
Back to Czechia47 clinical trials in Jihlava, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)CzechiaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
CzechiaA Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
CzechiaA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
CzechiaStudy comparing remibrutinib and ocrelizumab in patients with relapsing multiple sclerosis who switch from ocrelizumab treatment
CzechiaStudy on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis
CzechiaPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
CzechiaA study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease
CzechiaContinued Access Study for Patients with Neurological Disease Using Ocrelizumab and Drug Combination
CzechiaEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
CzechiaA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
CzechiaA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on multiple sclerosis treatments, including studies of novel therapies like frexalimab and comparative analyses of established medications. Clinical trials are evaluating both relapsing and progressive forms of MS, with emphasis on long-term efficacy and safety.
Several trials are investigating new delivery methods and formulations to improve patient outcomes.
Innovative studies targeting cardiovascular diseases, including trials for heart failure, myocardial infarction, and stroke prevention. Research includes evaluation of new compounds for reducing cardiovascular events and improving patient outcomes.
Focus on both preventive measures and acute treatment strategies for cardiovascular conditions.
Clinical trials examining new treatments for severe asthma and related respiratory conditions. Studies are evaluating novel medications and delivery systems to improve symptom control and reduce exacerbations.
Research emphasizes both immediate symptom relief and long-term disease control.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
